Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1998-11-18 (27 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LIBOURNE (33500), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU PINTEY : revenue, balance sheet and financial ratios
PHARMACIE DU PINTEY is a French company
founded 27 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LIBOURNE (33500),
this company of category PME
shows in 2018 a revenue of 4.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU PINTEY (SIREN 420860256)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
4 074 008 €
N/C
Net income
183 308 €
120 219 €
52 491 €
129 053 €
86 006 €
101 294 €
112 570 €
95 810 €
55 586 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
272 819 €
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2.4%
N/C
Revenue and income statement
In 2025, PHARMACIE DU PINTEY generates positive net income of 183 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 56 k€ -> 183 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
183 308 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 535%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
534.981%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
10.646%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
252.197
179.814
125.854
92.64
116.474
93.733
94.478
246.519
534.981
Financial autonomy
19.816
23.743
28.536
33.124
31.874
33.345
35.658
20.448
10.646
Repayment capacity
None
4.413
None
None
None
None
None
None
None
Cash flow / Revenue
None%
5.295%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
534.982025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch+18 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU PINTEY (534.98) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
10.65%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch-9 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU PINTEY (10.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 158.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
158.423
Liquidity indicators evolution PHARMACIE DU PINTEY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
134.419
144.7
143.722
127.142
176.299
149.334
158.69
191.61
158.423
Interest coverage
None
6.684
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
158.422025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average
In 2025, the liquidity ratio of PHARMACIE DU PINTEY (158.42) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 123 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1418 days. Excellent situation: suppliers finance 1295 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
123 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1418 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU PINTEY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
849 553 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
62
0
0
0
0
0
0
0
Customer payment term (days)
0
9
0
0
24
33
0
100
123
Supplier payment term (days)
0
72
0
0
837
684
0
812
1418
Positioning of PHARMACIE DU PINTEY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU PINTEY is estimated at
2 911 869 €
(range 1 976 008€ - 4 569 124€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1976k€2911k€4569k€
2 911 869 €Range: 1 976 008€ - 4 569 124€
NAF 5 année 2025
Valuation method used
Net Income Multiple
183 308 €
×
15.9x
=2 911 869 €
Range: 1 976 008€ - 4 569 124€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU PINTEY with other companies in the same sector:
Frequently asked questions about PHARMACIE DU PINTEY
What is the revenue of PHARMACIE DU PINTEY ?
The revenue of PHARMACIE DU PINTEY in 2018 is 4.1 M€.
Is PHARMACIE DU PINTEY profitable?
Yes, PHARMACIE DU PINTEY generated a net profit of 183 k€ in 2025.
Where is the headquarters of PHARMACIE DU PINTEY ?
The headquarters of PHARMACIE DU PINTEY is located in LIBOURNE (33500), in the department Gironde.
Where to find the tax return of PHARMACIE DU PINTEY ?
The tax return of PHARMACIE DU PINTEY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU PINTEY operate?
PHARMACIE DU PINTEY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart